First Trust Advisors LP
- SEC CIK
- 0001125816
- Latest filing
- Aug 11, 2026
DYN holding history
Dyne Therapeutics, Inc. in every 13F filed by First Trust Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DYN overviewAll 13F holders of DYNFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −32,283−100.0% | Sold out | Holders |
| Q3 2024 | 32,283 | $1.16M | <0.1% | +4,462+16.0% | Added | Holders |
| Q2 2024 | 27,821 | $981.8K | <0.1% | +27,821 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −36,984−100.0% | Sold out | Holders |
| Q2 2022 | 36,984 | $254.0K | <0.1% | −937−2.5% | Reduced | Holders |
| Q1 2022 | 37,921 | $366.0K | <0.1% | −2,201−5.5% | Reduced | Holders |
| Q4 2021 | 40,122 | $477.0K | <0.1% | +5,128+14.7% | Added | Holders |
| Q3 2021 | 34,994 | $568.0K | <0.1% | +34,994 | New | Holders |